propafenone has been researched along with Anti-MuSK Myasthenia Gravis in 2 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lecky, BR | 1 |
| Weir, D | 1 |
| Chong, E | 1 |
| Fierro, B | 1 |
| Castiglione, MG | 1 |
| Salemi, G | 1 |
| Savettieri, G | 1 |
2 other studies available for propafenone and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Exacerbation of myasthenia by propafenone.
Topics: Aged; Coronary Disease; Heart Ventricles; Humans; Male; Myasthenia Gravis; Neurologic Examination; P | 1991 |
Myasthenia-like syndrome induced by cardiovascular agents. Report of a case.
Topics: Aged; Cardenolides; Coronary Disease; Drug Therapy, Combination; Humans; Male; Myasthenia Gravis; Ne | 1987 |